Servo-Ventilation In-lab PSG Evaluation

Continuous Positive Airway Pressure (CPAP) is the most effective treatment for the Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS). CPAP stabilizes the airway and prevents instability and collapse. ...

Lead sponsor: Philips Respironics•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Philips Respironics

This study is to better understand the performance and features of the BiPAP autoSV Advanced System One. Philips Respironics will evaluate the PolySomnoGraphy (PSG) and Encore data from each night. The aim of the study is to characterize the acute outcomes of treatment provided by the device and evaluate any modifications made to the Philips Respironics device's algorithm The participants for this study will be experienced in having used servo ventilation therapy at their home because it is only such patients who are already using servo ventilation as part of routine clinical care that are eligible for participation. Participants will receive four (4) randomized PSG's during which they will receive treatment from the following devices in a randomized manner: * FDA released Philips BiPAP AutoSV Advanced System One * A Modified Philips BiPAP ASV * FDA released ResMed S7 VPAP Adapt * FDA released ResMed S9 VPAP Adapt The participants sought for this effort will be previously prescribed a servo-ventilation device as part of routine clinical care. Baseline with PSG * Informed Consent * Inclusion/Exclusion Criteria Review * Demographics * Anthropometric Measurements * PAP Prescription information (if available; from Device or from Medical records). This is the pressure settings of the device that was prescribed by the patient's clinical sleep medicine provider. * Medical History and physical examination * Sleep History- Including that past 30 day detailed report * Diagnostic PSG history (copies of sleep studies that were performed as part of routine clinical care in the past that qualified the patient for the servo-ventilation device) * Current Medications * Vital Signs (at beginning of PSG night) * Research Trial PSG- Randomized to a device Procedures for Each PSG after Baseline * Current Medications * Vital Signs (at beginning of PSG night) * Research Trial PSG- Randomized to one of the four devices (4 research PSGs will be performed for each subject). 30 day Take Home with Modified Philips BiPAP ASV device After the last PSG participants will be sent home on Modified Philips Auto Servo Ventilation (ASV) study device. A wireless modem with oxygen saturation level (SPO2) connection will be connected to the Modified Philips ASV study device. The wireless modem with SPO2 connection is for device data collection/transmission purposes only that monitors the usage and performance of the device in the home-setting. * The device setting should be set to the following: * P max: 30 * EPAP min: 4 * Expiratory Positive Airway Pressure maximum (EPAPmax):15 * Pressure Support Minimum (PS min): 0 * Pressure Support Maximum (PS max): 15 * BiFlex (Bi-Level Flex): 2 * Rate: Auto After 30 day Take Home Participants Will * Return to the Sleep Lab * Complete the end of study questionnaire * Return all of the study equipment Additional Take Home with the Modified Philips BiPAP ASV device: * Participants may be asked to use the Modified Philips ASV study device for an additional 30 days if more data is needed for analysis. Participants will complete the same end of day questionnaire noted above. After trial completion: * When the Participant is done with the trial they will go back to using their own prescribed device.

Related studies

RECRUITING

Clinical Characteristics of Patients With Sleep Apnea in Korea

NCT04186078 · Sleep Apnea Syndromes

RECRUITINGNA

Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis

NCT06578390 · Sleep Apnea Syndromes

RECRUITING

Apnea, Stroke and Incident Cardiovascular Events

NCT04399200 · Stroke, Sleep-disordered Breathing, and more

Enrolling By InvitationNA

Fascial Mobilization Along the Vagus Nerve and Its Effects on Acute Physiological Parameters in Obstructive Sleep Apnea

NCT07169058 · Obstructive Sleep Apnea Syndromes

Active Not Recruiting

Adverse Long-term Consequences of Sleep Disordered Breathing: The Ottawa Hospital (TOH) Sleep Database

NCT03834792 · Polysomnography, Sleep Apnea Syndromes, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 19, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment25

Start dateNov 2015

Last updatedMar 19, 2019

Condition

Sleep Apnea Syndromes

Locations shown

University of Arizona School of Medicine

Tucson, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions